OraSure Technologies (FRA:EP3) EV-to-EBIT : 7.47 (As of May. 26, 2024)

View and export this data going back to . Start your Free Trial

What is OraSure Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, OraSure Technologies's Enterprise Value is €99.8 Mil. OraSure Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €13.4 Mil. Therefore, OraSure Technologies's EV-to-EBIT for today is 7.47.

The historical rank and industry rank for OraSure Technologies's EV-to-EBIT or its related term are showing as below:

FRA:EP3' s EV-to-EBIT Range Over the Past 10 Years
Min: -141.74 Med: 14.53 Max: 290.44
Current: 7.57

During the past 13 years, the highest EV-to-EBIT of OraSure Technologies was 290.44. The lowest was -141.74. And the median was 14.53.

FRA:EP3's EV-to-EBIT is ranked better than
82.31% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs FRA:EP3: 7.57

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. OraSure Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was €187.1 Mil. OraSure Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €13.4 Mil. OraSure Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.14%.

OraSure Technologies EV-to-EBIT Historical Data

The historical data trend for OraSure Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies EV-to-EBIT Chart

OraSure Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

44.45

-88.60

-41.68

-48.12

7.51

OraSure Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															9.43	4.81	4.46	7.51	14.31

Competitive Comparison of OraSure Technologies's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, OraSure Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OraSure Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's EV-to-EBIT falls into.

OraSure Technologies EV-to-EBIT Calculation

OraSure Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	99.813	/	13.365
	=	7.47

OraSure Technologies's current Enterprise Value is €99.8 Mil.
OraSure Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.4 Mil.

OraSure Technologies (FRA:EP3) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

OraSure Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	13.365	/	187.14935
	=	7.14 %

OraSure Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was €187.1 Mil.
OraSure Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.4 Mil.

OraSure Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

OraSure Technologies (FRA:EP3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

OSUR:USA

Address

220 East First Street, Bethlehem, PA, USA, 18015

Website

https://www.orasure.com

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines